NCT06378957View on ClinicalTrials.gov

Behavioral Pharmacology of Orally Administered THC and D-limonene

PHASE1RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

February 14, 2025

Primary Completion Date

July 1, 2027

Study Completion Date

December 31, 2027

Conditions
Subjective Drug EffectsTHCD-limonene
Interventions
DRUG

D-Limonene

Oral Limonene administered via capsule

DRUG

Delta-9-THC

Oral delta-9-THC in ethanol vehicle administered via capsule

DRUG

Placebo

Placebo (cellulose) administered via capsule

Trial Locations (1)

21224

RECRUITING

Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER